New study aims to end guesswork in atrial fibrillation treatment

NCT ID NCT05084495

Completed Knowledge-focused Sponsor: Lund University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study followed 50 atrial fibrillation patients for 12 months to see if advanced heart imaging and ECG tests can predict whether the drug flecainide will keep their heart in normal rhythm. Researchers collected data during four clinic visits and analyzed it against outcomes like side effects and rhythm control. The goal is to move away from trial-and-error prescribing and give the right treatment to the right patient from the start.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors predict which atrial fibrillation patients will benefit from flecainide, reducing side effects and improving treatment success.
What could go wrong: This is a small observational study, not a treatment trial. The findings may not apply to all patients and need confirmation in larger studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION

Contacts and locations

Locations

Clinical Sciences, Helsingborg Medical Faculty Lund University

Helsingborg, Skåne County, 25187, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.